0001213900-22-012651.txt : 20220316 0001213900-22-012651.hdr.sgml : 20220316 20220315193731 ACCESSION NUMBER: 0001213900-22-012651 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220315 FILED AS OF DATE: 20220316 DATE AS OF CHANGE: 20220315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SciSparc Ltd. CENTRAL INDEX KEY: 0001611746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38041 FILM NUMBER: 22742849 BUSINESS ADDRESS: STREET 1: 20 RAUL WALLENBERG STREET, TOWER A CITY: TEL AVIV STATE: L3 ZIP: 6971916 BUSINESS PHONE: 972-3-6103100 MAIL ADDRESS: STREET 1: 20 RAUL WALLENBERG STREET, TOWER A CITY: TEL AVIV STATE: L3 ZIP: 6971916 FORMER COMPANY: FORMER CONFORMED NAME: SciSparc Ltd./ADR DATE OF NAME CHANGE: 20210129 FORMER COMPANY: FORMER CONFORMED NAME: Therapix Biosciences Ltd. DATE OF NAME CHANGE: 20140624 6-K 1 ea156953-6k_scisparc.htm REPORT OF FOREIGN PRIVATE ISSUER

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of March 2022 (Report No. 3)

 

Commission file number: 001-38041

 

SCISPARC LTD.

(Translation of registrant’s name into English)

 

20 Raul Wallenberg Street, Tower A,

Tel Aviv 6971916 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒   Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

 

 

 

 

CONTENTS

 

Resignation of a Board Member

 

On March 13, 2022, Mr. Moshe Revach tendered his resignation from the board of directors of SciSparc Ltd. (the “Board” and “Company”, respectively). Mr. Revach advised the Company that he has decided to step down from the Board effective immediately. Mr. Revach stated that his resignation is due to personal reasons and not due to any disagreements or Company-related issues.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SciSparc Ltd.
   
Date: March 15, 2022 By: /s/ Oz Adler
    Name:  Oz Adler
    Title: Chief Executive Officer &
Chief Financial Officer

 

2